PAVmed
PAVM
28 hedge funds and large institutions have $735K invested in PAVmed in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 4 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
24% more capital inflows, than outflows
Capital inflows: $36.4K | Capital outflows: $29.2K
0.19% less ownership
Funds ownership: 7.36% → 7.17% (-0.19%)
3% less funds holding
Funds holding: 29 → 28 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$28K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$5.07K |
| 3 |
Raymond James Financial
St Petersburg,
Florida
|
+$1.66K |
| 4 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$1.16K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$220 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XTX Topco
George Town,
Cayman Islands
|
-$16.9K |
| 2 |
Virtu Financial
New York
|
-$8K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.66K |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$1.62K |
| 5 |
Binnacle Investments
Urbandale,
Iowa
|
-$48 |
PAVM Hedge Fund Activity: Q2 2025 in Review
28 of the 7,627 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2025, worth a combined $735K — down 16% from $873K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PAVM and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 6 added.
The largest buyer was Jane Street, adding an estimated $28K. The largest seller was XTX Topco, exiting entirely with an estimated $16.9K sold.
- 28 institutional investors held PAVmed (PAVM) as of Q2 2025, down from 29 in Q1 2025.
- Funds reported $735K of PAVmed stock for Q2 2025, down 16% quarter-over-quarter.
- 3 funds opened new PAVmed positions in Q2 2025 and 4 closed out, a net change of -1 holder.
- The largest PAVmed buyer in Q2 2025 was Jane Street, an estimated $28K added.
- The largest PAVmed seller in Q2 2025 was XTX Topco, an estimated $16.9K sold.
Based on aggregated 13F filings for Q2 2025.